We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$451M
AUM Growth
-$16.1M
Cap. Flow
-$29.1M
Cap. Flow %
-6.45%
Top 10 Hldgs %
36.92%
Holding
175
New
4
Increased
16
Reduced
46
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$13M
2
APTV icon
Aptiv
APTV
+$8.34M
3
JPM icon
JPMorgan Chase
JPM
+$3.81M
4
ALKS icon
Alkermes
ALKS
+$2.41M
5
V icon
Visa
V
+$2.03M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.7M
2
SWN
Southwestern Energy Company
SWN
+$10.7M
3
APA icon
APA Corp
APA
+$10.6M
4
AGN
Allergan plc
AGN
+$7.65M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.27M

Sector Composition

Rank Sector Weight
1 Financials 23.48%
2 Technology 17.62%
3 Healthcare 14.5%
4 Energy 9.7%
5 Consumer Staples 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQR icon
101
Equity Residential
EQR
$24.6B
$129K 0.03%
2,011
– –
INFO
102
DELISTED
IHS Markit Ltd. Common Shares
INFO
$110K 0.02%
3,100
– –
SYT
103
DELISTED
Syngenta Ag
SYT
$103K 0.02%
1,300
– –
CAT icon
104
Caterpillar
CAT
$392B
$102K 0.02%
1,100
– –
CWT icon
105
California Water Service
CWT
$3.04B
$102K 0.02%
3,000
– –
GLD icon
106
SPDR Gold Trust
GLD
$143B
$99K 0.02%
900
– –
AMZN icon
107
Amazon
AMZN
$2.96T
$94K 0.02%
2,500
– –
VFC icon
108
VF Corp
VFC
$5.9B
$93K 0.02%
1,859
-533
-22% -$27.6K
LLY icon
109
Eli Lilly
LLY
$1.09T
$92K 0.02%
1,250
– –
OLED icon
110
Universal Display
OLED
$4.28B
$90K 0.02%
1,600
– –
D icon
111
Dominion Energy
D
$59.1B
$89K 0.02%
1,158
– –
MLI icon
112
Mueller Industries
MLI
$15.4B
$88K 0.02%
8,800
– –
META icon
113
Meta Platforms (Facebook)
META
$1.56T
$86K 0.02%
750
– –
DD
114
DELISTED
Du Pont De Nemours E I
DD
$77K 0.02%
1,055
– –
BXP icon
115
Boston Properties
BXP
$10.8B
$76K 0.02%
606
– –
ECL icon
116
Ecolab
ECL
$80.1B
$70K 0.02%
600
– –
SBUX icon
117
Starbucks
SBUX
$121B
$69K 0.02%
1,240
– –
VSM
118
DELISTED
Versum Materials, Inc.
VSM
$62K 0.01%
+2,200
New +$54.8K
ZTS icon
119
Zoetis
ZTS
$31.1B
$61K 0.01%
1,146
– –
FNV icon
120
Franco-Nevada
FNV
$46.5B
$60K 0.01%
1,000
– –
VOD icon
121
Vodafone
VOD
$36.5B
$57K 0.01%
2,334
-5,448
-70% -$143K
REGN icon
122
Regeneron Pharmaceuticals
REGN
$82.9B
$55K 0.01%
150
– –
UL icon
123
Unilever
UL
$134B
$55K 0.01%
1,200
-1,067
-47% -$49.7K
AU icon
124
AngloGold Ashanti
AU
$49.6B
$53K 0.01%
5,000
– –
CB icon
125
Chubb
CB
$134B
$50K 0.01%
375
– –
3 4
5
6 7

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Kelly Lawrence W & Associates held 175 positions worth $451M, down 3.4% from $467M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $29.1M in Q4 2016, closing 15 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Kelly Lawrence W & Associates opened a new position in Aptiv worth $8.36M.

  • Kelly Lawrence W & Associates's largest Q4 2016 buy was Aptiv: 124,175 shares worth $8.36M.
  • Kelly Lawrence W & Associates added most to Merck in Q4 2016, an estimated $13M increase.
  • Kelly Lawrence W & Associates's biggest Q4 2016 reduction was APA Corp, cutting an estimated $10.6M.
  • Kelly Lawrence W & Associates fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $10.7M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 37% of its $451M portfolio in Q4 2016.
  • Kelly Lawrence W & Associates opened 4 new positions and closed 15 in Q4 2016.
  • Kelly Lawrence W & Associates's portfolio value fell 3.4% quarter-over-quarter to $451M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.